826 related articles for article (PubMed ID: 19879701)
1. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
[TBL] [Abstract][Full Text] [Related]
3. Second cancers in children treated with modern radiotherapy techniques.
Schneider U; Lomax A; Timmermann B
Radiother Oncol; 2008 Nov; 89(2):135-40. PubMed ID: 18707783
[TBL] [Abstract][Full Text] [Related]
4. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
5. The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer.
Schneider U; Lomax A; Besserer J; Pemler P; Lombriser N; Kaser-Hotz B
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):892-7. PubMed ID: 17459608
[TBL] [Abstract][Full Text] [Related]
6. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
7. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).
Studer G; Studer SP; Zwahlen RA; Huguenin P; Grätz KW; Lütolf UM; Glanzmann C
Strahlenther Onkol; 2006 May; 182(5):283-8. PubMed ID: 16673062
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
[TBL] [Abstract][Full Text] [Related]
9. Secondary neutron doses for several beam configurations for proton therapy.
Shin D; Yoon M; Kwak J; Shin J; Lee SB; Park SY; Park S; Kim DY; Cho KH
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):260-5. PubMed ID: 19362245
[TBL] [Abstract][Full Text] [Related]
10. Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy.
Athar BS; Paganetti H
Phys Med Biol; 2009 Aug; 54(16):4907-26. PubMed ID: 19641238
[TBL] [Abstract][Full Text] [Related]
11. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
[TBL] [Abstract][Full Text] [Related]
12. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)].
Marchal C; Lapeyre M; Beckendorf V; Aletti P; Haslé E; Dubois JB; Maingon P; Bensadoun RJ; Le Prise E; Lartigau E; Carrie C; Dubray B; Marchesi V; Ailleres N; Naudy S; Marcie S; Manens JP; Mazurier J; Ginestet C; Chauvin F; Pommier P; Gerard JP; Carrere MO
Cancer Radiother; 2004 Nov; 8 Suppl 1():S121-7. PubMed ID: 15679257
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
Hall EJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
17. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies.
Ruben JD; Davis S; Evans C; Jones P; Gagliardi F; Haynes M; Hunter A
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1530-6. PubMed ID: 18207670
[TBL] [Abstract][Full Text] [Related]
18. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
[TBL] [Abstract][Full Text] [Related]
19. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer.
Krayenbuehl J; Davis JB; Ciernik IF
Radiother Oncol; 2006 Nov; 81(2):151-7. PubMed ID: 17055095
[TBL] [Abstract][Full Text] [Related]
20. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]